| Date Filed | Type | Description |
| 12/21/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/01/2022 |
SC 13D/A
| White Winston Select Asset Fund Series Fund MP-18, LLC reports a 9% stake in MusclePharm Corporation |
| 03/31/2022 |
4
| White Winston Select Asset Fund Series Fund MP-18, LLC (10% Owner) has filed a Form 4 on MusclePharm Corp|
Txns:
| Sold 626,826 shares
@ $0 |
|
| 02/22/2022 |
SC 13D/A
| White Winston Select Asset Fund Series Fund MP-18, LLC reports a 10.9% stake in MusclePharm Corporation |
| 11/08/2019 |
SC 13D/A
| White Winston Select Asset Fund Series Fund MP-18, LLC reports a 11.3% stake in MusclePharm Corporation |
| 11/08/2019 |
4/A
| White Winston Select Asset Fund Series Fund MP-18, LLC (10% Owner) has filed a Form 4 on MusclePharm Corp|
Txns:
| Bought 626,826 shares
@ $0 |
|
| 11/08/2019 |
4/A
| White Winston Select Asset Fund Series Fund MP-18, LLC (10% Owner) has filed a Form 4 on MusclePharm Corp|
Txns:
| Bought 93,852 shares
@ $0 |
|
| 10/07/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2019 |
4
| White Winston Select Asset Fund Series Fund MP-18, LLC (10% Owner) has filed a Form 4 on MusclePharm Corp|
Txns:
| Bought 103,677 shares
@ $0 |
|
| 08/06/2019 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 08/02/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/24/2018 |
SC 13D/A
| White Winston Select Asset Fund Series Fund MP-18, LLC reports a 19.9% stake in MusclePharm Corporation |
| 07/02/2018 |
3
| White Winston Select Asset Fund Series Fund MP-18, LLC (10% Owner) has filed a Form 3 on MusclePharm Corp |
| 06/29/2018 |
SC 13D
| White Winston Select Asset Fund Series Fund MP-18, LLC reports a 19.9% stake in MusclePharm Corporation |
| 04/24/2018 |
D
| Form D - Notice of Exempt Offering of Securities: |